Pharmacogenomics on inferagen
CYP2D6, CYP2C19, DPYD, TPMT, and full CPIC-aligned PGx panels with star-allele assignment.
Clinical context
PGx is moving from research into routine clinical practice in India — driven by oncology (DPYD before 5-FU), psychiatry (CYP2D6/2C19), and cardiology (CYP2C19/clopidogrel). inferagen runs PGx panels with full star-allele resolution, CPIC guideline annotations, and a clinician-readable medication-by-medication report.
What we deliver
On inferagen.
- CYP2D6 with full structural variant detection (the hardest gene in PGx)
- 100+ pharmacogenes with CPIC/PharmGKB annotations
- Star-allele to phenotype mapping
- Drug-by-drug actionability report (not just gene-by-gene)
- Indian-population allele frequency context (key for *2, *3, *17 variants)
Sample report
See exactly what your clinician will receive.
An anonymized PDF for this exact test type — patient summary, clinician summary, and ACMG detail. PII removed.
Download sample reportPricing
Credits per sample.
100–400 credits per sample (~₹2,000 – ₹8,000).
See full pricing & credit consumption →Design-partner programme
First design partners running this in beta — talk to us to be next.
We're onboarding a small group of labs for this test type. Design partners get free credits, white-glove onboarding, and direct input into our roadmap.
Apply to be a design partner →